On Dec. 23, the FDA approved Hikma Pharmaceuticals’ liraglutide injection, a generic version of Novo Nordisk’s Victoza.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA approves GLP-1 generic
On Dec. 23, the FDA approved Hikma Pharmaceuticals’ liraglutide injection, a generic version of Novo Nordisk’s Victoza.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis